Anastrozole and levonorgrestrel-releasing intrauterine device in the treatment of endometriosis: a randomized clinical trial
Abstract Background To study the effectiveness of an aromatase inhibitor (Anastrozole) associated with levonorgestrel-releasing intrauterine device (LNG-IUD, Mirena®) in the treatment of endometriosis. Methods Prospective, randomized clinical trial. Setting: University Hospital (single center). Eleg...
Saved in:
Main Authors: | Pedro Acién (Author), Irene Velasco (Author), Maribel Acién (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endometriosis and ovarian cancer: Their association and relationship
by: Ernesto Bas-Esteve, et al.
Published: (2019) -
Classification of Müllerian anomalies: Is a consensus possible?
by: Maribel Acién, et al.
Published: (2022) -
Clinical pilot study to evaluate the neovaginal PACIENA prosthesis® for vaginoplasty without skin grafts in women with vaginal agenesis
by: Pedro Acién, et al.
Published: (2019) -
Intrauterine lidocaine and naproxen for analgesia during intrauterine device insertion: randomized controlled trial
by: Shana M. Miles, et al.
Published: (2019) -
Rectum penetration that was caused by the displacement of an intrauterine device and mimicked rectal endometriosis
by: Shu-Fen Weng, et al.
Published: (2011)